Delivery Order SPE2DB24D9801-SPE2DB25FKYBX
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,986.59 by the Defense Logistics Agency on September 8, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This contract, valued at $3,664.15 with an ultimate completion date of August 6, 2025, carries no set-aside designation and represents a single delivery order under the DLA's broader pharmaceutical supply...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,542.80, is for the delivery of the pharmaceutical product ondansetron hydrochloride. The delivery order has a period of performance through March 3, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the SPE2DB program with the Defense Logistics Agency (DLA). The $6,132.60 contract is for the delivery of ondansetron hydrochloride 8 mg tablets to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $3,209.86 firm-fixed-price delivery order is for the supply of 4,568,155,855 units of Ondansetron HCL 4 mg tablets. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a wide range of...
- The Defense Logistics Agency awarded a delivery order valued at $1,826.19 to DMS Pharmaceutical Group Inc. for the supply of Ondansetron ODT 8 mg tablets (30-count packages) under a firm fixed-price contract type. The award was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and performance will be executed from Conshohocken, Pennsylvania. This delivery order was not issued under a set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,085.60 by the Defense Logistics Agency's Medical Supply Chain on June 4, 2025, for the supply of Ondansetron Hydrochloride. The contract employs firm fixed-price pricing with an ultimate completion date of June 16, 2025. This delivery order was issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,021.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,558,233,358 units of Ondansetron HCL 4 mg tablets. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The IDC allows the DLA to issue firm...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,780.34 firm fixed-price delivery order is for the supply of 4560062223 - Ondansetron ODT 4 MG Tablet 30S, with a completion date of February 28, 2023. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,994.48 firm fixed-price delivery order is for the supply of Ondansetron 8mg tablets to support the recurring medical needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
- SPE2DB24D9801Indefinite Delivery Contract
- SPE2DB24D9801-SPE2DB25FKYBXDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,892.75 by the Defense Logistics Agency on September 23, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This delivery order was issued without a set-aside designation and carries an ultimate completion date of September 24, 2025. The contract represents a continuation of DMS Pharmaceutical Group's significant role as a key supplier within the federal pharmaceutical supply chain, leveraging its established position as a woman-owned small business to compete in federal procurement markets. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The Defense Logistics Agency, operating under the Department of Defense, utilizes this contract vehicle to ensure efficient and cost-effective distribution of critical pharmaceutical products to Department of Defense healthcare sites globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/23/25 |